Why eating less doesn't always move fat

Cutting portion sizes, skipping dessert, tracking calories — and yet the fat stubbornly stays put. For many people in their forties and beyond, this is not a failure of willpower but a sign that something upstream of the calorie count is running the show. That something is insulin.

Insulin is a small peptide hormone produced by the pancreas — two short amino-acid chains locked together by disulfide bonds — and it operates less like a simple blood-sugar gauge and more like a master routing switch for energy. When it binds to tyrosine kinase receptors on the surface of liver, muscle, and fat cells, it fires off a cascade of phosphorylation signals that simultaneously direct glucose into glycogen stores, convert any surplus into triglycerides, and support protein synthesis. In plain terms: insulin tells the body to build and store.

What makes insulin so consequential for anyone trying to shift body fat is what it does to lipolysis — the process by which stored fat is broken down and released as fuel. Insulin powerfully suppresses hormone-sensitive lipase, the enzyme that unlocks fat reserves. At chronically high concentrations, it does not merely slow fat burning; it effectively locks the door to those reserves altogether, regardless of how little is on the plate.

A clinical observation from X-PERT Health illustrates just how far this override can reach. Individuals placed in a 300 kcal daily energy deficit were given supplemental insulin; rather than losing the predicted 6.5 kg over six months, they gained an average of 8.7 kg. The caloric deficit was real — and irrelevant. Insulin had rerouted the outcome entirely.

This is the central reframe that Professor Paul Lee's Regeneration by Design builds on within the Chemistry pillar: insulin is not a passive responder to what you eat. At elevated levels it is an active gatekeeper — and understanding which lever raises it is the first step in designing a way around it.

The fat–inflammation loop that feeds itself

Sustained high insulin does more than prevent fat burning — it gradually transforms fat tissue itself into a source of systemic disruption.

Here is what happens when insulin stays elevated for months or years. As it continuously shuttles glucose into triglycerides and blocks lipolysis, adipocytes swell. Eventually the surrounding capillary network cannot keep pace: cells outgrow their oxygen supply, and hypoxic adipocytes begin releasing distress signals — principally TNF-alpha and IL-6. These cytokines recruit macrophages into fat tissue and establish a state of chronic, low-grade inflammation.

The cycle then turns on itself. TNF-alpha and IL-6 do not merely cause inflammation; they also block the IRS-1 arm of the insulin receptor, the very pathway that allows cells to respond to insulin normally. As sensitivity falls, the pancreas secretes more insulin; more insulin drives more fat deposition; more swollen adipocytes release more cytokines. The loop closes.

Critically, the link between poor glucose control and raised inflammatory markers holds even after adjusting for body weight. A cross-sectional study of 367 people found that worsening glycaemic control predicted higher IL-6 and TNF-alpha independently of BMI. Inflammation is not simply a downstream consequence of carrying excess weight — the insulin axis contributes through mechanisms of its own, making it a driver as much as a bystander.

This is where Chemistry begins to destabilise Biology. An inflamed, insulin-resistant fat depot impairs tissue repair, disrupts energy regulation, and narrows the body's recovery windows. It is precisely this kind of cross-pillar cascade — hormonal chemistry compounding into biological dysfunction — that Professor Paul Lee addresses in Regeneration by Design, and why systemic thinking about the internal environment matters before the downstream consequences accumulate.

Carbohydrate as the upstream controller

Of the three macronutrients, carbohydrate has by far the most direct and potent effect on insulin secretion. Protein triggers a modest insulin response; dietary fat triggers almost none. The quantity of carbohydrate consumed — and how quickly it raises blood glucose — is therefore the dominant upstream variable in the entire fat-storage–inflammation system described in the previous two sections.

This relationship has been formalised as the Carbohydrate-Insulin Model, published by researcher David Ludwig in 2018 and cited more than 667 times since. Its core proposition is that high-glycaemic-load foods — those that flood the bloodstream with glucose rapidly — produce a hormonal environment that directs calories preferentially into fat storage, suppresses energy expenditure, and amplifies hunger signals. The model has its critics: some researchers argue that total energy intake and dietary fat composition are equally important variables, and that position is not without merit. The honest summary is that carbohydrate is the most direct and responsive lever, not the only one.

What makes carbohydrate reduction so useful as a practical starting point is the concept of metabolic flexibility — the body's innate capacity to switch fluidly between burning glucose and burning fat as conditions change. Chronically high glycaemic loads effectively lock the system into one mode; moderating them restores that switching capacity. The goal is not zero carbohydrate but a recalibrated internal environment in which fat reserves remain accessible when the body needs them. This is precisely the kind of systemic Chemistry intervention that underpins the practical approach set out in Professor Paul Lee's Regeneration by Design.

What happens when you pull the lever — the evidence

Five distinct bodies of evidence — different populations, different designs, different durations — converge on the same direction when dietary carbohydrate is reduced.

On fat oxidation and metabolic markers, a weight-maintenance RCT (JCI Insight, 2019) fed obese participants with metabolic syndrome equal-calorie diets varying only in carbohydrate content. Despite identical caloric intake, the low-carbohydrate arm reversed metabolic syndrome — improving triglycerides, raising HDL-C, and shifting LDL towards larger, less-atherogenic particles — confirming that the operative lever is carbohydrate composition, not calorie count. A 12-week ketogenic diet (~9% of energy from carbohydrate) in adults with mild type 2 diabetes reduced liver fat by 28% and cut the de novo lipogenesis marker palmitoleic acid by 32%, alongside a measurable shift in hepatic metabolism towards fat oxidation. A real-world clinic study of 202 overweight adults on therapeutic carbohydrate restriction found that fat oxidation improved in 84% of participants within approximately two weeks; at 12 weeks, 71% of total weight lost had come from fat, with an average 4.9 cm reduction in waist circumference. Even a single day of reducing carbohydrate intake to 50 g was sufficient to lower postprandial triglycerides and reduce the respiratory quotient — effects similar to short-term fasting, and independent of total caloric intake.

On inflammation, a 12-week RCT in 160 patients with coronary artery disease found that a low-glycaemic-index diet significantly reduced hs-CRP, TNF-alpha, and IL-6 compared with a routine diet — the same three markers central to the fat–inflammation loop described earlier.

Their convergence across separate laboratories and study designs strengthens the signal considerably. The honest caveat is that most of these trials are short (4–12 weeks) and conducted in people with established metabolic or cardiovascular conditions; long-term data in the broader 40–70+ wellness population without overt disease remain thinner. What this body of evidence does support is that moderating dietary glycaemic load may help maintain a healthy weight, supports metabolic flexibility, and supports healthy inflammation markers — practical outcomes that sit squarely within the Chemistry pillar of Regeneration by Design.

Three practical shifts you can make this week

Knowing the mechanism is useful; acting on it need not be complicated. Three modest shifts — stackable, reversible, no calorie counting required — are enough to begin moving the Chemistry lever meaningfully.

Audit glycaemic load, not calories

Identify the two or three items in a typical day that spike insulin most sharply: sugary drinks, ultra-processed snacks, refined grains eaten on their own. Reducing or swapping just those items begins to lower the average insulin environment your body operates in — without touching anything else.

Sequence what you eat

Protein and fat consumed before refined carbohydrate at the same meal blunts the post-meal insulin rise — a small architectural change with a measurable physiological effect. Starting lunch with the protein course, or adding eggs and olive oil before bread appears, costs nothing but a moment's intention.

Build in a daily eating window

A rough 12:8 pattern — eating within an eight-hour window — creates a daily low-insulin period that may support fat mobilisation without any calorie arithmetic. The window does the work.

Two early signals suggest the system is responding: stable energy between meals and quieter afternoon hunger indicate the body is drawing on fat fuel rather than waiting for its next glucose fix. These are the subjective hallmarks of metabolic flexibility returning.

For a more objective read, routine blood chemistry panels and glucose awareness tools can confirm what the body is actually doing at a biochemical level — an approach central to the data-informed healthspan design Professor Lee outlines in Regeneration by Design. That same data-first thinking is what makes the Chemistry pillar inseparable from the others.

Insulin chemistry inside the Regeneration by Design framework

All four sections converge on a single reorientation: fat accumulation and low-grade inflammation are not primarily problems of willpower or caloric arithmetic — they are downstream consequences of a hormonal environment shaped, meal by meal, largely by carbohydrate choices. That shift changes the productive question. Rather than 'how little can I eat?', the more useful frame is 'what am I asking my insulin to do?'

Within Professor Paul Lee's four-pillar system, this is Chemistry doing its foundational work — but genuinely intertwined with the others. Chronically elevated insulin impairs the tissue-repair capacity that the Physics pillar depends on: metabolically stressed, inflamed tissue rebuilds more slowly after physical load. Sleep quality and insulin sensitivity are also tightly linked — poor sleep raises next-day insulin resistance, pulling the Biology and Chemistry pillars into the same feedback loop. The pillars are not independent levers; insulin sits at a junction where all four converge.

Regeneration by Design (July 2024) laid out this systemic view for a general audience; Practical Regeneration (February 2026) translates it into the day-to-day protocols that move each pillar in practice. Routine blood chemistry and glucose-awareness tools give the Chemistry pillar its feedback loop — not diagnosis, but data that makes metabolic patterns legible and allows genuine progress to be confirmed rather than merely assumed.

This article is for general wellness information only. For individual medical concerns, please consult a qualified healthcare professional.

1. [1] Insulin — Wikipedia. https://en.wikipedia.org/?curid=14895 https://en.wikipedia.org/?curid=14895
2. [2] Insulin Signal Transduction Pathway — Wikipedia. https://en.wikipedia.org/?curid=31216882 https://en.wikipedia.org/?curid=31216882
3. [3] Isolating the acute metabolic effects of carbohydrate restriction on postprandial metabolism with or without energy restriction: a crossover study. (2025). https://doi.org/10.1007/s00394-025-03646-5 https://doi.org/10.1007/s00394-025-03646-5
4. [4] Beneficial Effects of Carbohydrate Restriction in Type 2 Diabetes Can Be Traced to Changes in Hepatic Metabolism. (2025). https://doi.org/10.1210/clinem/dgaf324 https://doi.org/10.1210/clinem/dgaf324
5. [5] Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss. (2019). https://doi.org/10.1172/jci.insight.128308 https://doi.org/10.1172/jci.insight.128308
6. [6] Type 2 Diabetes is Associated With Elevated Levels of TNF-alpha, IL-6 and Adiponectin and Low Levels of Leptin. (2011). https://doi.org/10.1016/j.cyto.2011.09.029 https://doi.org/10.1016/j.cyto.2011.09.029